TheClubDeal

Because finding the right partner in the fast-growing digital environment is a hard task, we have built an online multi-criteria searching tool strongly linked to professional networks and peer-to-peer recommendations. Sortlist helps marketing managers find their partners in minutes and let them focus on building communication and marketing success. Start your search now on www.sortlist.com

Univercells SA, founded in 2013 and based in Gosselies, Belgium, specializes in the design, development, and implementation of single-use bioprocess solutions for biomanufacturing. The company offers a comprehensive range of services, including the design and construction of manufacturing facilities, as well as the maintenance and supply of bulk active pharmaceutical ingredients (APIs). With a focus on vaccines and biologics, Univercells employs innovative engineering techniques that significantly reduce investment needs by over 75% and lower production costs by up to 90%. Their approach integrates three manufacturing steps—cell culture under perfusion, clarification, and capture—into a simulated continuous mode, enhancing efficiency in the production of antibodies, proteins, and vaccines. Additionally, Univercells has established a strategic partnership with Takeda Pharmaceutical Company to further advance its capabilities in the biomanufacturing sector.

Univercells SA, founded in 2013 and based in Gosselies, Belgium, specializes in the design, development, and implementation of single-use bioprocess solutions for biomanufacturing. The company offers a comprehensive range of services, including the design and construction of manufacturing facilities, as well as the maintenance and supply of bulk active pharmaceutical ingredients (APIs). With a focus on vaccines and biologics, Univercells employs innovative engineering techniques that significantly reduce investment needs by over 75% and lower production costs by up to 90%. Their approach integrates three manufacturing steps—cell culture under perfusion, clarification, and capture—into a simulated continuous mode, enhancing efficiency in the production of antibodies, proteins, and vaccines. Additionally, Univercells has established a strategic partnership with Takeda Pharmaceutical Company to further advance its capabilities in the biomanufacturing sector.

Provider of hospitality and accommodation services intended to give people the flexibility to stay wherever they want for as long as they want. The company provides flexible housing, events, food, drinks and services with a baseline of art and culture, enabling young urban individuals and travelers to connect with like-minded people and explore places at their own convenience.

Graftys SAS, based in Aix-en-Provence, France, specializes in the design, development, and manufacturing of synthetic bone biomaterials aimed at reconstructive orthopedic surgery. Founded in 2005, the company provides a range of innovative products, including Graftys QuickSet, a calcium phosphate cement with properties akin to cancellous bone, and biphasic calcium phosphates used for bone repair in surgical procedures. Other offerings include BioActys Granule and Graftys HBS, a cement that transforms into a plastic paste when mixed with a liquid phase. Graftys' products are utilized in various medical applications, such as the fixation of endoprostheses, treatment of bone tumors, and procedures in dentistry and oral surgery, including pulp protection and bone regeneration support.

Univercells SA, founded in 2013 and based in Gosselies, Belgium, specializes in the design, development, and implementation of single-use bioprocess solutions for biomanufacturing. The company offers a comprehensive range of services, including the design and construction of manufacturing facilities, as well as the maintenance and supply of bulk active pharmaceutical ingredients (APIs). With a focus on vaccines and biologics, Univercells employs innovative engineering techniques that significantly reduce investment needs by over 75% and lower production costs by up to 90%. Their approach integrates three manufacturing steps—cell culture under perfusion, clarification, and capture—into a simulated continuous mode, enhancing efficiency in the production of antibodies, proteins, and vaccines. Additionally, Univercells has established a strategic partnership with Takeda Pharmaceutical Company to further advance its capabilities in the biomanufacturing sector.

3D-Side is a medical technology company, spin-off of the UCL University, which took up the challenge to link surgeons to 3D technology! Thanks to 3D software, additive manufacturing and strong knowledge of the surgical field, 3D-Side set up a complete ISO13485 workflow to plan complex interventions and provide surgeons with cranial implants or advanced solutions for bone surgery. After years of industrialization and with the aim of being efficient, improve traceability and get high satisfaction from customers, 3D-Side developed Customize, a web-based Software as a Service solution (SaaS) consisting of 3 modules: • A communication tool to interact easily with surgeons • A design program to create custom-made instruments or implants • A production management interface to supervise the just-in-time manufacturing. 3D-Side’s products have already proven the platform efficiency by making their processes much more efficient, holding out the same promise for the working practices of other manufacturers. Using Customize will enable them to efficiently commercialize custom-made medical devices, while also allowing surgeons to easily send medical images, visualize the 3D surgical planning and supervise the engineering work through a secured channel, with as main objective to have everything ready for the surgery.

Operator of a biotechnology firm intended to develop an innovative chemo library and medicinal chemistry. The company's firm helps to focus on the development of a kinase platform involved in the treatment of diseases of the central nervous system, inflammation, cancer, and metabolic diseases and also provides screening technology for the discovery of selective and potent kinase inhibitors, enabling clients to get technology-enhanced drugs for treatment.

Bezonia is a universal integration platform enabling people to orchestrate the most scalable technological ecosystems.

Lawbox is an online service designed to address the legal needs of entrepreneurs by providing a range of personalized legal documents. The platform offers model contracts, letters, and other essential legal documents that are validated by experienced lawyers. Users can easily create these documents by responding to a questionnaire that tailors the content to their specific requirements. In addition to document creation, Lawbox assists clients in managing legal formalities related to business operations, recruitment, brand protection, and dispute resolution. This service aims to make legal processes faster, easier, and more cost-effective for entrepreneurs.

Vivalto Home offers independent, dependent or disoriented elderly people a network of nursing homes or Residences Services.